Chroma Ventures
Dundee, United Kingdom11
2M
8
3.67
1
0.27
1
- Stages of investment
- Areas of investment
Investor highlights
- Industry generalist
- Yes
- Industry focus
- Stage focus
- Geo focus
- Check size
- 624K — 6M
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 11
- Lead investments
- 1
- Exits
- 1
- Rounds per year
- 3.67
- Follow on index
- 0.27
- Investments by industry
- Gaming (4)
- Software (3)
- Search Engine (2)
- Insurance (2)
- Commercial Insurance (2) Show 15 more
- Investments by region
- United Kingdom (9)
- United States (1)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Group Appearance index
- 0.36
- Avg. company exit year
- 8
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Puny Astronaut | 01 Jan 2021 | Software, Gaming, Innovation Management, Playstation | Seed | Dundee, Dundee City, United Kingdom |
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Anocca | Aug 19, 2025 | Autoimmune diseases, Biopharmaceutical, Cancer Cell Therapies, Cell Therapies, Cell Therapy Manufacturing, Gene-edited TCR-T cell therapies, Oncology, Programmable human cells, T-cell immunotherapies, T-cell receptor-engineered T cell therapies, T-cell Receptors, T-cell Receptors (TCRs), T-cells, T-cell Therapies, Vaccines | - | 46000000 USD |  Södertälje |
| Anocca | May 31, 2023 | Autoimmune diseases, Biopharmaceutical, Cancer Cell Therapies, Cell Therapies, Cell Therapy Manufacturing, Gene-edited TCR-T cell therapies, Oncology, Programmable human cells, T-cell immunotherapies, T-cell receptor-engineered T cell therapies, T-cell Receptors, T-cell Receptors (TCRs), T-cells, T-cell Therapies, Vaccines | - | 36580000 USD | Södertälje |
| H2 Green Steel | Oct 19, 2022 | climate-tech, CO2 Emissions Reduction, end-to-end digitalization, fossil-free electricity, green hydrogen, green steel, Green Steel, Hydrogen, Renewable Energy | - | 260000000 EUR | Stockholm |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.